Moderna Inc (MRNA)
Current ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 10,325,000 | 13,431,000 | 16,071,000 | 6,298,000 | 1,128,800 |
| Total current liabilities | US$ in thousands | 3,015,000 | 4,923,000 | 9,128,000 | 4,389,000 | 143,115 |
| Current ratio | 3.42 | 2.73 | 1.76 | 1.43 | 7.89 |
December 31, 2023 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $10,325,000K ÷ $3,015,000K
= 3.42
The current ratio of Moderna Inc has shown fluctuations over the past five years, ranging from 1.43 in 2020 to 3.42 in 2023. The ratio indicates the company's ability to cover its short-term liabilities with its current assets.
In 2019, the current ratio was unusually high at 7.89, suggesting a robust ability to meet short-term obligations. However, this ratio decreased significantly in subsequent years, reaching its lowest point in 2020 at 1.43, indicating a potential liquidity concern that year.
Since then, the current ratio has been on an upward trend, reaching 2.73 in 2022 and further improving to 3.42 in 2023. This upward trend indicates a strengthening liquidity position, with the company having more current assets to cover its short-term obligations.
Overall, the current ratio analysis suggests that Moderna Inc has improved its liquidity position in recent years, with a higher current ratio indicating a better ability to meet its short-term financial obligations.
Peer comparison
Dec 31, 2023